Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
65.4 USD | -2.51% | -0.72% | -18.92% |
12:07pm | North American Morning Briefing : More Tech -2- | DJ |
Apr. 24 | HSBC Upgrades Gilead Sciences to Hold From Reduce, Price Target is $69 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.92% | 83.65B | |
+23.76% | 562B | |
-6.60% | 358B | |
+18.53% | 322B | |
+7.35% | 297B | |
+12.85% | 219B | |
+6.00% | 199B | |
-10.39% | 196B | |
-11.01% | 149B | |
-6.78% | 146B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Gilead Sciences : Galapagos Halted Lung Disease Drug Candidate Expected to Account For 4% of Revenue in 2030, Mizuho Says